28
Oct
2025

AMW

Exhibitor at CPHI Frankfurt 2025 stand 3.1B67, Finished Dosage Formulations
About Us

AMW as pharmaceutical company develops and manufactures improved medicines to optimize therapeutic outcomes and enhance patient well-being. With state-of-the-art production facilities in Germany, the entire pharmaceutical value chain is covered. Our mission is to provide patients and our partners with value-added medicines. Our biodegradable sustained-release drug delivery systems help improve medication adherence and allow for cost-effective therapies. Based on our technology platform, we build on a growing own and partnered development pipeline. We hereby cover the entire value ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DE
  • 2021
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1B67, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Goserelin 10,8mg (3-Month Implant)

    Product Goserelin 10,8mg (3-Month Implant)

    The active ingredient goserelin is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Thus, goserelin intake has indirect effects on testosterone levels in men, the lowering of which stops the growth of malignant cancerous tumors. In a...
  • Goserelin 3,6mg (1-Month Implant)

    Product Goserelin 3,6mg (1-Month Implant)

    The active ingredient goserelin is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Thus, goserelin intake has indirect effects on testosterone levels in men, the lowering of which stops the growth of malignant cancerous tumors. In a...
  • Leuprolide 3-Month Implant

    Product Leuprolide 3-Month Implant

    The active ingredient leuprorelin, like goserelin, is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Administration of leuprorelin has indirect effects on testosterone levels in men, the lowering of which stops the growth of malign...